- Home
- YI vs OKUR Comparison
YI vs OKUR Comparison
Compare YI & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YI
- OKUR
- Stock Information
- Founded
- YI 2010
- OKUR 2011
- Country
- YI China
- OKUR United States
- Employees
- YI N/A
- OKUR N/A
- Industry
- YI Retail-Drug Stores and Proprietary Stores
- OKUR
- Sector
- YI Consumer Staples
- OKUR
- Exchange
- YI Nasdaq
- OKUR NYSE
- Market Cap
- YI 68.5M
- OKUR 76.6M
- IPO Year
- YI N/A
- OKUR N/A
- Fundamental
- Price
- YI $8.26
- OKUR $5.20
- Analyst Decision
- YI
- OKUR Strong Buy
- Analyst Count
- YI 0
- OKUR 4
- Target Price
- YI N/A
- OKUR $35.00
- AVG Volume (30 Days)
- YI 46.0K
- OKUR 78.2K
- Earning Date
- YI 03-20-2025
- OKUR 02-25-2025
- Dividend Yield
- YI N/A
- OKUR N/A
- EPS Growth
- YI N/A
- OKUR N/A
- EPS
- YI N/A
- OKUR N/A
- Revenue
- YI $2,090,255,896.00
- OKUR N/A
- Revenue This Year
- YI $61.85
- OKUR N/A
- Revenue Next Year
- YI N/A
- OKUR N/A
- P/E Ratio
- YI N/A
- OKUR N/A
- Revenue Growth
- YI N/A
- OKUR N/A
- 52 Week Low
- YI $0.41
- OKUR $4.58
- 52 Week High
- YI $8.81
- OKUR $20.00
- Technical
- Relative Strength Index (RSI)
- YI 87.81
- OKUR N/A
- Support Level
- YI $6.88
- OKUR N/A
- Resistance Level
- YI $8.44
- OKUR N/A
- Average True Range (ATR)
- YI 0.50
- OKUR 0.00
- MACD
- YI -0.01
- OKUR 0.00
- Stochastic Oscillator
- YI 78.83
- OKUR 0.00
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.